Cargando…
Enhancement of soluble CD28 levels in the serum of Graves’ disease
Graves’ disease is an autoimmune disease of the thyroid gland mediated by T cells. CD28, a member of costimulatory molecules, plays a pivotal role in regulating T-cell responses. Plasma-soluble CD28 is one form of CD28 in peripheral blood. To investigate the concentrations of soluble CD28 in patient...
Autores principales: | Sun, Zhongwen, Yi, Lixian, Tao, Hong, Huang, Jingfang, Jin, Zhenghong, Xiao, Yang, Feng, Caiyun, Sun, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Society of Experimental and Clinical Immunology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440026/ https://www.ncbi.nlm.nih.gov/pubmed/26155127 http://dx.doi.org/10.5114/ceji.2014.43726 |
Ejemplares similares
-
Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease
por: Metwalley, Kotb Abbass, et al.
Publicado: (2020) -
Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves’ disease
por: Mizuguchi, Yuki, et al.
Publicado: (2018) -
Serum concentrations of TNF-α and its soluble receptors in Graves’ disease
por: Zhu, Qing, et al.
Publicado: (2020) -
Association of CD28 IVS3 +17T/C Polymorphism with Soluble CD28 in Rheumatoid Arthritis
por: Ledezma-Lozano, I. Y., et al.
Publicado: (2011) -
The association between serum adenosine deaminase levels and Graves’ disease
por: Lu, Chun-feng, et al.
Publicado: (2021)